Latest filing published 25 Oct 2017 for GlaxoSmithKline plc, €49k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Philip Hampton: trading record in brief
All filings by Philip Hampton on record concern GlaxoSmithKline plc. Between 26 April 2017 and 25 October 2017, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 3 purchases, €150k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The median purchase comes to €49k.
On 25 October 2017 came the latest disclosure, an open-market purchase for €49k in GlaxoSmithKline plc. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, UK MAR gives managers three business days to notify a trade. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Philip Hampton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,882.082 shares@ £15.1848.8% of flown/aISIN GB0009252882FCA-NSM:LSE20171025152118_13409025_20200330131538139_17441-0Canonical exit: 23 Jan 2018 (T+90)
- 2,736.085 shares@ £15.9932.7% of flown/aISIN GB0009252882FCA-NSM:LSE20170726132247_13308370_20200330131517640_18500-0Canonical exit: 24 Oct 2017 (T+90)
- 2,763.74 shares@ £15.8351.2% of flown/aISIN GB0009252882FCA-NSM:LSE20170427174026_13207549_20200330131501285_19100-0Canonical exit: 25 Jul 2017 (T+90)
3 of 3 declarations